Company intelligence / Profile preview

SummerBio

Menlo Park, California, United States

Ownership: Private
Employees: ~51
Development stage: Other

Overview

SummerBio developed and operated an end-to-end automated high-throughput COVID-19 testing system using RT-PCR assays. The company processed over 20 million tests with an 11-hour average turnaround time and an average price of $13 per test. It operated a CLIA-certified laboratory. The company wound down its large-scale PCR operations as the COVID-19 response evolved post-pandemic.

Therapeutic areas: Infectious Diseases
Industry: Molecular Diagnostics

Partnerships

UCLALos Angeles Unified School District

Beyond the preview

Go deeper on SummerBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SummerBio.

Explore the full profile